Picard Medical gets NYSE American nod on compliance plan

Go back to Picard Medical gets NYSE American nod on compliance plan

Picard Medical Receives NYSE American Acceptance of Compliance Plan

July 27, 2026 7:00 AM EDT

TUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the Company or Picard Medical), parent company of SynCardia Systems LLC, maker of the worlds first and only total artificial heart approved by both the U.S. FDA and Health Canada, today announced that the NYSE American LLC (NYSE American) has accepted the Companys plan to regain compliance with the exchanges continued listing standards under Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.

The acceptance of the Companys compliance plan allows Picard Medical to continue listing and trading... More